H
Howard H. Bailey
Researcher at University of Wisconsin-Madison
Publications - 98
Citations - 4343
Howard H. Bailey is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Cancer & Pharmacokinetics. The author has an hindex of 33, co-authored 94 publications receiving 4086 citations. Previous affiliations of Howard H. Bailey include University of Southern California & Vanderbilt University.
Papers
More filters
Journal ArticleDOI
Constitutive and β-Naphthoflavone-induced Expression of the Human γ-Glutamylcysteine Synthetase Heavy Subunit Gene Is Regulated by a Distal Antioxidant Response Element/TRE Sequence
TL;DR: The data indicate that the constitutive and β-NF-induced expression of the human GCS heavy subunit gene is mediated by a distal ARE sequence containing an embedded tetradecanoylphorbol-13-acetate-responsive element.
Journal ArticleDOI
Enhancing the bioavailability of resveratrol by combining it with piperine.
Jeremy J. Johnson,Minakshi Nihal,Imtiaz A. Siddiqui,Cameron O. Scarlett,Howard H. Bailey,Hasan Mukhtar,Nihal Ahmad +6 more
TL;DR: Piperine significantly improves the in vivo bioavailability of resveratrol through inhibiting its glucuronidation, thereby slowing its elimination and further detailed research is needed to study the mechanism of improved bioavailability via its combination with piperine.
Journal ArticleDOI
Chemoprevention of Nonmelanoma Skin Cancer With Celecoxib: A Randomized, Double-Blind, Placebo-Controlled Trial
Craig A. Elmets,Craig A. Elmets,Jaye L. Viner,Jaye L. Viner,Alice P. Pentland,Wendy Cantrell,Hui Yi Lin,Hui Yi Lin,Howard H. Bailey,Sewon Kang,Sewon Kang,Kenneth G. Linden,Michael J. Heffernan,Michael J. Heffernan,Madeleine Duvic,Ellen Richmond,Boni E. Elewski,Asad Umar,Walter C. Bell,Gary Gordon +19 more
TL;DR: Celecoxib may be effective for prevention of SCCs and BCCs in individuals who have extensive actinic damage and are at high risk for development of nonmelanoma skin cancers.
Journal ArticleDOI
Green tea polyphenols for prostate cancer chemoprevention: a translational perspective.
TL;DR: The data that has been collected so far suggests that green tea may be a promising agent for PCa chemoprevention and further clinical trials of participants at risk of PCa or early stage PCa are warranted.
Journal ArticleDOI
Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione.
Howard H. Bailey,R T Mulcahy,Kendra D. Tutsch,Rhoda Z. Arzoomanian,D. Alberti,Mary Beth Tombes,George Wilding,Marcia Pomplun,David R. Spriggs +8 more
TL;DR: This study shows that BSO alone and in combination with L-PAM can be safely given to patients, but that a schedule of short infusions every 12 hours does not result in GSH depletion less than 30% of baseline values.